CHEBI:75045 - dabrafenib

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name dabrafenib
ChEBI ID CHEBI:75045
Definition An organofluorine compound and antineoplastic agent, used as its mesylate salt in treatment of metastatic melanoma.
Stars This entity has been manually annotated by the ChEBI Team.
Supplier Information
Download Molfile XML SDF
more structures >>
Wikipedia License
Waiting for wikipedia content
Read full article at Wikipedia
Formula C23H20F3N5O2S2
Net Charge 0
Average Mass 519.56200
Monoisotopic Mass 519.10105
InChI InChI=1S/C23H20F3N5O2S2/c1-23(2,3)21-30-18(19(34-21)16-10-11-28-22(27)29-16)12-6-4-9-15(17(12)26)31-35(32,33)20-13(24)7-5-8-14(20)25/h4-11,31H,1-3H3,(H2,27,28,29)
InChIKey BFSMGDJOXZAERB-UHFFFAOYSA-N
SMILES CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(s1)-c1ccnc(N)n1
Roles Classification
Chemical Role(s): Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
Biological Role(s): anticoronaviral agent
Any antiviral agent which inhibits the activity of coronaviruses.
B-Raf inhibitor
A serine/threonine kinase inhibitor that specifically inhibits human mutant serine/threonine kinase (B-Raf)
Application(s): antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing dabrafenib (CHEBI:75045) has role anticoronaviral agent (CHEBI:149553)
dabrafenib (CHEBI:75045) has role antineoplastic agent (CHEBI:35610)
dabrafenib (CHEBI:75045) has role B-Raf inhibitor (CHEBI:75047)
dabrafenib (CHEBI:75045) is a 1,3-thiazoles (CHEBI:38418)
dabrafenib (CHEBI:75045) is a aminopyrimidine (CHEBI:38338)
dabrafenib (CHEBI:75045) is a organofluorine compound (CHEBI:37143)
dabrafenib (CHEBI:75045) is a sulfonamide (CHEBI:35358)
Incoming dabrafenib mesylate (CHEBI:75048) has part dabrafenib (CHEBI:75045)
IUPAC Name
N-{3-[5-(2-aminopyrimidin-4-yl)-2-tert-butyl-1,3-thiazol-4-yl]-2-fluorophenyl}-2,6-difluorobenzenesulfonamide
INN Source
dabrafenib ChemIDplus
Manual Xrefs Databases
4801 DrugCentral
D10064 KEGG DRUG
Dabrafenib Wikipedia
LSM-6303 LINCS
WO2011047238 Patent
View more database links
Registry Numbers Types Sources
1195765-45-7 CAS Registry Number ChemIDplus
19689971 Reaxys Registry Number Reaxys
Citations Waiting for Citations Types Sources
22981500 PubMed citation Europe PMC
23237741 PubMed citation Europe PMC
23249624 PubMed citation Europe PMC
23276366 PubMed citation Europe PMC
23290787 PubMed citation Europe PMC
23317446 PubMed citation Europe PMC
23403819 PubMed citation Europe PMC
23463215 PubMed citation Europe PMC
23470635 PubMed citation Europe PMC
23515890 PubMed citation Europe PMC
23537694 PubMed citation Europe PMC
23552670 PubMed citation Europe PMC
23608920 PubMed citation Europe PMC
23617957 PubMed citation Europe PMC
23621583 PubMed citation Europe PMC
23656699 PubMed citation Europe PMC
23709751 PubMed citation Europe PMC
23714462 PubMed citation Europe PMC
23795808 PubMed citation Europe PMC
23807941 PubMed citation Europe PMC
23833299 PubMed citation Europe PMC
23844038 PubMed citation Europe PMC
23846776 PubMed citation Europe PMC
23870055 PubMed citation Europe PMC
23881668 PubMed citation Europe PMC
Last Modified
23 April 2020